Výsledky vyhledávání - "Hanne Theilgaard"

Developing, Planning and Conducting an Interim Analysis: Lessons From the DEVOTE Cardiovascular Outcomes Trial (Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Patients With Type 2 Diabetes at High Risk of Cardiovascular Events)

Autor: Lars Endahl, Shawn Hoskin, Inger Mollerup, Anders Hvelplund, Alan C. Moses, Hanne Theilgaard, Ida Carøe Helmark, Lene Klixbüll Amby

Publikováno v: Therapeutic Innovation & Regulatory Science. 53:279-286

In 2013, a randomized, double-blind, active comparator-controlled, event-driven cardiovascular outcomes trial (DEVOTE) was initiated to compare the cardiovascular safety of insulin degludec (degludec) versus insulin glargine 100 units/mL (glargine U1

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd66a8b36846e354b438b48adb10feb4
https://doi.org/10.1177/2168479018776943

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání